title: Vascular smooth muscle function: defining the diabetic vascular phenotype.
abstract: In this issue of Diabetologia, a meta-analysis performed by Montero and co-authors (Diabetologia doi 10.1007/s00125-013-2974-1 ) demonstrates a significant impairment of vascular smooth muscle (VSM) function in type 2 diabetic patients. Endothelial function and VSM function between type 2 diabetic and healthy individuals were associated, especially in the microcirculation, confirming the hypothesis that unresponsiveness of VSM cells to NO may amplify the consequences of reduced NO availability. This study suggests a novel interpretation for endothelial dysfunction in diabetic patients, indicating VSM cells as key players. Causative mechanisms of VSM dysfunction, which seems to be a feature of the vascular phenotype of type 2 diabetes mellitus, are largely unexplored in humans. Future studies should also address the crucial issue of the prognostic significance of VSM dysfunction in diabetic patients, and possibly in other conditions characterised by high cardiovascular risk.
authors.affiliation: Institute of Clinical Physiology - CNR, Via G Moruzzi 1, 56124 Pisa, Italy. rosam.bruno@gmail.com
authors.forename: Rosa Maria
authors.initials: RM
authors.lastname: Bruno
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Ghiadoni
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000473:pathology*; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000473:pathology*
references.citation: J Hypertens. 2012 Jul;30(7):1399-405
references.pmid: 22525207
references.citation: Am J Physiol Heart Circ Physiol. 2001 Sep;281(3):H1304-11
references.pmid: 11514301
references.citation: Hypertension. 2010 May;55(5):1075-85
references.pmid: 20351340
references.citation: Circulation. 2005 Jan 25;111(3):363-8
references.pmid: 15668353
references.citation: N Engl J Med. 2006 Nov 9;355(19):2003-11
references.pmid: 17093251
references.citation: Endocrinology. 2008 Apr;149(4):1480-9
references.pmid: 18079207
references.citation: J Am Coll Cardiol. 2010 Dec 14;56(25):e50-103
references.pmid: 21144964
references.citation: Diabetologia. 2012 Jun;55(6):1847-55
references.pmid: 22411135
references.citation: Eur Heart J. 2010 Nov;31(22):2741-8
references.pmid: 20974801
references.citation: Am J Physiol Endocrinol Metab. 2008 Oct;295(4):E732-50
references.pmid: 18612041
references.citation: J Am Coll Cardiol. 2002 Jan 16;39(2):257-65
references.pmid: 11788217
references.citation: Am J Physiol Heart Circ Physiol. 2011 Jan;300(1):H2-12
references.pmid: 20952670
references.citation: J Hypertens. 2005 Jan;23(1):7-17
references.pmid: 15643116
references.citation: Diabetologia. 2013 Oct;56(10):2122-33
references.pmid: 23864267
references.citation: Circulation. 2002 Dec 10;106(24):3037-43
references.pmid: 12473548
references.citation: Int J Cardiovasc Imaging. 2010 Aug;26(6):631-40
references.pmid: 20339920